Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-10-09

FDA Approved: HALCION — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

FDA approved a supplemental application for HALCION (triazolam) from Pharmacia & Upjohn Company LLC, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALCION (TRIAZOLAM)

Snippet

SUPPL AP for HALCION (TRIAZOLAM)